Detection and characterization of circulating tumor cells in lung cancer: Why and how?

Cancer Cytopathol. 2016 Jun;124(6):380-7. doi: 10.1002/cncy.21651. Epub 2015 Nov 20.

Authors

Véronique J Hofman^{1

2

3

4}, Marius Ilie^{1

2

3

4}, Paul M Hofman^{1

2

3

4}

Affiliations

¹ Laboratory of Clinical and Experimental Pathology, Pasteur Hospital, Nice, France.
² Hospital-Related Biobank (BB 0025-00033), Pasteur Hospital, Nice, France.
³ "OncoAge" Hospital-University Federation, Pasteur Hospital, Nice, France.
⁴ IRCAN, Inserm U1081/UMR CNRS 7284 Team 3, University of Nice Sophia Antipolis, Nice, France.

PMID: 26587794
DOI: 10.1002/cncy.21651

No abstract available

MeSH terms

Biomarkers, Tumor / analysis*
Humans
Lung Neoplasms / blood*
Lung Neoplasms / pathology*
Neoplastic Cells, Circulating / pathology*

Substances

Biomarkers, Tumor